These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2334394)

  • 41. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets.
    Bajpai A; Kwon BS; Brahmi Z
    Immunology; 1991 Oct; 74(2):258-63. PubMed ID: 1721042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.
    Cherin P; Herson S; Crevon MC; Hauw JJ; Cervera P; Galanaud P; Emilie D
    J Rheumatol; 1996 Jul; 23(7):1135-42. PubMed ID: 8823683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Na+/Ca2+ exchanger regulates cytolysin/perforin-induced increases in intracellular Ca2+ and susceptibility to cytolysis.
    Kraut RP; Bose R; Cragoe EJ; Greenberg AH
    J Immunol; 1992 Apr; 148(8):2489-96. PubMed ID: 1560205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extracellular release of lymphocyte cytolytic pore-forming protein (perforin) after ionophore stimulation.
    Young JD; Leong LG; Liu CC; Damiano A; Cohn ZA
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5668-72. PubMed ID: 2426703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: A critical role for aspartate residues 429, 435, 483, and 485 but not 491.
    Voskoboinik I; Thia MC; Fletcher J; Ciccone A; Browne K; Smyth MJ; Trapani JA
    J Biol Chem; 2005 Mar; 280(9):8426-34. PubMed ID: 15576364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional size of complement and perforin pores compared by confocal laser scanning microscopy and fluorescence microphotolysis.
    Sauer H; Pratsch L; Tschopp J; Bhakdi S; Peters R
    Biochim Biophys Acta; 1991 Mar; 1063(1):137-46. PubMed ID: 2015253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Perforin. A family of killer proteins.
    Stanley K; Luzio P
    Nature; 1988 Aug; 334(6182):475-6. PubMed ID: 3261390
    [No Abstract]   [Full Text] [Related]  

  • 48. A pore-forming protein, perforin, from a non-mammalian organism, Japanese flounder, Paralichthys olivaceus.
    Hwang JY; Ohira T; Hirono I; Aoki T
    Immunogenetics; 2004 Aug; 56(5):360-7. PubMed ID: 15322778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transients of perforin pore formation observed by fluorescence microscopic single channel recording.
    Peters R; Sauer H; Tschopp J; Fritzsch G
    EMBO J; 1990 Aug; 9(8):2447-51. PubMed ID: 1695147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proliferation, esterase activity, and propidium iodide exclusion in urologic tumor cells after in vitro exposure to chemotherapeutic agents.
    Flanigan RC; Pavlik EJ; Van Nagell JR; Keaton K; Kenady DE
    J Urol; 1986 May; 135(5):1091-100. PubMed ID: 3959237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Flow cytometry cannot assess surface binding of perforin to target cells.
    Metkar SS; Aguilar-Santelises M; Wang B; Froelich CJ
    Blood; 2001 Apr; 97(7):2181-3. PubMed ID: 11286222
    [No Abstract]   [Full Text] [Related]  

  • 52. Cytofluorescence localization of propidium iodide injected intravenously into the nervous system of the mouse.
    Hussain ST; Attilo A; Bigotte L; Cesarini K; Olsson Y
    Acta Neuropathol; 1985; 66(1):62-7. PubMed ID: 3873165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Propidium iodide as a nuclear marker in immunofluorescence. I. Use with tissue and cytoskeleton studies.
    Ockleford CD; Hsi BL; Wakely J; Badley RA; Whyte A; Faulk WP
    J Immunol Methods; 1981; 43(3):261-7. PubMed ID: 7019343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Membrane damage effect of continuous wave ultrasound on K562 human leukemia cells.
    Wang P; Li Y; Wang X; Guo L; Su X; Liu Q
    J Ultrasound Med; 2012 Dec; 31(12):1977-86. PubMed ID: 23197551
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-lethal effects of perforin on polymorphonuclear leukocytes.
    Hopkins JI; Jones J; Morgan BP
    Biochem Soc Trans; 1998 Feb; 26(1):S50. PubMed ID: 10909808
    [No Abstract]   [Full Text] [Related]  

  • 56. Intracellular Ca2+ and cell injury: a paradoxical role of Ca2+ in complement membrane attack.
    Morgan BP; Luzio JP; Campbell AK
    Cell Calcium; 1986 Dec; 7(5-6):399-411. PubMed ID: 3545490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imaging bioluminescent indicators shows Ca2+ and ATP permeability thresholds in live cells attacked by complement.
    Sala-Newby GB; Taylor KM; Badminton MN; Rembold CM; Campbell AK
    Immunology; 1998 Apr; 93(4):601-9. PubMed ID: 9659235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of medium conductivity and composition on the uptake of propidium iodide into electropermeabilized myeloma cells.
    Djuzenova CS; Zimmermann U; Frank H; Sukhorukov VL; Richter E; Fuhr G
    Biochim Biophys Acta; 1996 Oct; 1284(2):143-52. PubMed ID: 8914578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temporary Membrane Permeabilization via the Pore-Forming Toxin Lysenin.
    Shrestha N; Thomas CA; Richtsmeier D; Bogard A; Hermann R; Walker M; Abatchev G; Brown RJ; Fologea D
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32456013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Esterase activity, exclusion of propidium iodide, and proliferation in tumor cells exposed to anticancer agents: phenomena relevant to chemosensitivity determinations.
    Pavlik EJ; Flanigan RC; van Nagell JR; Hanson MB; Donaldson ES; Keaton K; Doss B; Bartmas J; Kenady DE
    Cancer Invest; 1985; 3(5):413-26. PubMed ID: 4052831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.